North China Pharmaceutical Surgeon Who Re

North China Pharmaceutical Surgeon Who Re

Are you looking for place to read full E-Books without downloading? You can also read and download new and old full E-Books. Free Download Health Book


 North China Pharmaceutical Surgeon Who Re


With the North Pharmacy Announced today: Hebei Energy Club chairman Wang Ping was elected the new chairman of the company, North China Pharmaceutical reorganization "surgeon" and this debut. It also means re-Jizhong Energy Group North China Pharmaceutical advance preparation has been completed. After the establishment of new leadership, the company's restructuring will enter a substantive stage. Community level for the current






Wang Jizhong Energy Group Co., Ltd. chairman and party secretary, general manager; Hebei Jinniu Energy Co. chairman and party secretary; China Pharmaceutical Group Corporation chairman, party secretary, party secretary of the company. Background information, social Ping Wang considerable restructuring experience, he single-handedly guided the Xing Han mine and mine restructuring, set up Jinniu Energy Group, and later with Jingxing Bureau of Mines, the coal around the joint reorganization, and hosted the Babaoshan mine, the integration of many small local coal mines, was the industry as the "gold can model." The chairman of the board he intended to serve North China Pharmaceutical China regarding the hands-on medicine restructuring.






However, social Ping Wang, chairman of the North China Pharmaceutical sit here after there is impairment. North China Pharmaceutical Company According to the original articles of association: "do not have Medicine Industry for more than five years of senior management experience of the "can not serve as director of North China Pharmaceutical, and Wang social level curriculum vitae shows that he does not have any work experience in the pharmaceutical industry. Therefore, in this Aug. 13 shareholder meeting, proposed amendments Articles of Association of the motion, that is the original charter: "No more than five years with the pharmaceutical industry senior management experience of the" delete the contents of this motion was adopted by the General Assembly of shareholders, only then to enter the king lay the social level Road.






From North China Pharmaceutical company disclosed the composition of the new management team of view, except the king community level, the company's vice chairman, deputy general manager and other senior management staff are Chinese medicines that "elderly", which also revealed a lack of medicine experience in the field of social Ping Wang, the role will be to speed up the recent reorganization of the North China Pharmaceutical advance.






Focus SAC in Hebei Province, the Hebei North China Pharmaceutical concerning energy restructuring is at full speed. By the end of June, when he was chairman Wang Jizhong Energy Agency level part-time chairman of the North China Pharmaceutical Group. August 4, Hebei Province, China Pharmaceutical Group, the SASAC to adjust the ratio of capital to 100% and 100% stake in China Pharmaceutical Group transferred to Hebei energy, enabling energy to China Hebei Pharmaceutical Group, a wholly-owned holding. The entire process took only a few month's time.






Now, on the North China Pharmaceutical there before the two re-drama. One, led by energy restructuring in central Hebei. Jizhong Energy Web site, according to the information display, Hebei Hebei Province, the most powerful energy is large enterprise groups. 2008 operating income of 41 billion yuan, profit 3.6 billion. Following the success of this year's May issue 2 billion yuan corporate bonds, the recently completed main coal industry as a whole listing of the preliminary work, the overall market is expected to recently approved. Obviously, Jizhong Energy powerful capital strength will help solve the North China Pharmaceutical Chain shortages of funds. The second is the announcement in March this year, NCPC and the Dutch DSM company's strategy Cooperation And asset restructuring matters. How will the two re-disposal, this is the new leadership in North China Pharmaceutical things need to be carefully considered.


Are you looking full ebook about this topicGet Full Ebook For This Article